Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Julius Semenas"'
Autor:
Johan Wänman, Kasim Abul-Kasim, Julius Semenas, Elin Thysell, Anders Bergh, Pernilla Wikström, Sead Crnalic
Publikováno v:
European Urology Open Science, Vol 48, Iss , Pp 44-53 (2023)
Background: Prostate cancer spinal bone metastases can have a radiographic profile that mimics multiple myeloma. Objective: To analyse the presence and prognostic value of myeloma-like prostate cancer bone metastases and its relation to known clinica
Externí odkaz:
https://doaj.org/article/663aaae897454f51885b906ab47fb96b
Autor:
Per Flodbring Larsson, Richard Karlsson, Martuza Sarwar, Regina Miftakhova, Tianyan Wang, Azharuddin Sajid Syed Khaja, Julius Semenas, Sa Chen, Andreas Hedblom, Amjad Ali, Kristina Ekström‐Holka, Athanasios Simoulis, Anjani Kumar, Anette Gjörloff Wingren, Brian Robinson, Sun Nyunt Wai, Nigel P. Mongan, David M. Heery, Daniel Öhlund, Thomas Grundström, Niels Ødum, Jenny L. Persson
Publikováno v:
Molecular Oncology, Vol 16, Iss 13, Pp 2496-2517 (2022)
Low‐affinity immunoglobulin gamma Fc region receptor III‐A (FcγRIIIa) is a cell surface protein that belongs to a family of Fc receptors that facilitate the protective function of the immune system against pathogens. However, the role of FcγRII
Externí odkaz:
https://doaj.org/article/b9424d66238242208aa13b376f19daab
Autor:
Elin Thysell, Linda Köhn, Julius Semenas, Helena Järemo, Eva Freyhult, Marie Lundholm, Camilla Thellenberg Karlsson, Jan‐Erik Damber, Anders Widmark, Sead Crnalic, Andreas Josefsson, Karin Welén, Rolf J. A. Nilsson, Anders Bergh, Pernilla Wikström
Publikováno v:
Molecular Oncology, Vol 16, Iss 4, Pp 846-859 (2022)
To improve treatment of metastatic prostate cancer, the biology of metastases needs to be understood. We recently described three subtypes of prostate cancer bone metastases (MetA‐C), based on differential gene expression. The aim of this study was
Externí odkaz:
https://doaj.org/article/65f5c75dc7eb47b6a1f8e39de3159faa
Autor:
Julius Semenas, Tianyan Wang, Azharuddin Sajid Syed Khaja, AKM Firoj Mahmud, Athanasios Simoulis, Thomas Grundström, Maria Fällman, Jenny L. Persson
Publikováno v:
Molecular Oncology, Vol 15, Iss 4, Pp 968-986 (2021)
Selective ERα modulator, tamoxifen, is well tolerated in a heavily pretreated castration‐resistant prostate cancer (PCa) patient cohort. However, its targeted gene network and whether expression of intratumor ERα due to androgen deprivation thera
Externí odkaz:
https://doaj.org/article/76e6e359dd224187a7177058d52aa91f
Autor:
Tianyan Wang, Martuza Sarwar, Jonathan B Whitchurch, Hilary M Collins, Tami Green, Julius Semenas, Amjad Ali, Christopher J Roberts, Ryan D Morris, Madlen Hubert, Sa Chen, Zahra El-Schich, Anette G Wingren, Thomas Grundström, Richard Lundmark, Nigel P Mongan, Lena Gunhaga, David M Heery, Jenny L Persson
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 10 (2022)
PIP5K1α has emerged as a promising drug target for the treatment of castration-resistant prostate cancer (CRPC), as it acts upstream of the PI3K/AKT signaling pathway to promote prostate cancer (PCa) growth, survival and invasion. However, little is
Externí odkaz:
https://doaj.org/article/6f00bee0afbc4bf1a1d8d8f354c3e273
Autor:
Anna Mandel, Per Larsson, Martuza Sarwar, Julius Semenas, Azharuddin Sajid Syed Khaja, Jenny L. Persson
Publikováno v:
Molecular Medicine, Vol 24, Iss 1, Pp 1-13 (2018)
Abstract Background Metastatic Prostate cancer (PCa) cells have gained survival and invasive advantages. Epidermal growth factor (EGF) receptor is a receptor tyrosine kinase, which may mediate signalling to promote progression and invasion of various
Externí odkaz:
https://doaj.org/article/fd38b65cea2b4951aa6f4b3410782470
Autor:
Martina Tinzl, Binshen Chen, Shao-Yong Chen, Julius Semenas, Per-Anders Abrahamsson, Nishtman Dizeyi
Publikováno v:
PLoS ONE, Vol 13, Iss 12, p e0209544 (2018)
[This corrects the article DOI: 10.1371/journal.pone.0079573.].
Externí odkaz:
https://doaj.org/article/a8f258e0fddf40f6a2a467d33ce262d5
Autor:
Martina Tinzl, Binshen Chen, Shao-Yong Chen, Julius Semenas, Per-Anders Abrahamsson, Nishtman Dizeyi
Publikováno v:
PLoS ONE, Vol 8, Iss 11, p e79573 (2013)
Taxane based chemotherapy is the standard of care treatment in castration resistant prostate cancer (CRPC). There is convincing evidence that taxane therapy affects androgen receptor (AR) but the exact mechanisms have to be further elucidated. Our st
Externí odkaz:
https://doaj.org/article/c9fca333663a44018cb8abcfc2d52046
Autor:
Jenny L. Persson, Cinzia Allegrucci, Norman J. Maitland, Nigel P. Mongan, David M. Heery, Albert Rizvanov, Johan Malm, Athanasios Simoulis, Brian Robinson, Julius Semenas, Andreas Hedblom, Regina Miftakhova
Evaluate bone marrow metastasis initiated by PC3M cells via intracardiac injection of tumor cells into mice.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32c3a9d987b9293154b7d9628c500130
https://doi.org/10.1158/0008-5472.22410941.v1
https://doi.org/10.1158/0008-5472.22410941.v1
Autor:
Jenny L. Persson, Cinzia Allegrucci, Norman J. Maitland, Nigel P. Mongan, David M. Heery, Albert Rizvanov, Johan Malm, Athanasios Simoulis, Brian Robinson, Julius Semenas, Andreas Hedblom, Regina Miftakhova
Supplemental Materials and Methods and figure text for supplemental figures
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::517e94424e186cb851c4b407292b00e4
https://doi.org/10.1158/0008-5472.22410938.v1
https://doi.org/10.1158/0008-5472.22410938.v1